NF1 MUTATION
Clinical trials for NF1 MUTATION explained in plain language.
Never miss a new study
Get alerted when new NF1 MUTATION trials appear
Sign up with your email to follow new studies for NF1 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New stem cell method aims to cut transplant complications in blood cancer patients
Disease control Recruiting nowThis study tests a new way to prepare stem cells for transplant in children and adults with blood cancers like leukemia. The method removes certain immune cells to lower the risk of graft-versus-host disease, a serious side effect. About 70 participants will receive the treatment…
Matched conditions: NF1 MUTATION
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 17, 2026 07:34 UTC
-
New pill hopes to shrink painful NF1 tumors without surgery
Disease control Recruiting nowThis early-stage study tests a daily pill called PAS-004 in adults with neurofibromatosis type 1 (NF1) who have at least one symptomatic, inoperable nerve tumor (plexiform neurofibroma). The main goals are to find safe doses and understand side effects. The study has two parts: P…
Matched conditions: NF1 MUTATION
Phase: PHASE1 • Sponsor: Pasithea Therapeutics Corp. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New cancer pill enters first human safety trial
Disease control Recruiting nowThis is the first study in people testing an experimental pill called PAS-004 for advanced solid tumors that have specific genetic mutations (RAS, NF1, or RAF) or have stopped responding to standard treatments. The main goals are to find a safe dose, understand the side effects, …
Matched conditions: NF1 MUTATION
Phase: PHASE1 • Sponsor: Pasithea Therapeutics Corp. • Aim: Disease control
Last updated Apr 17, 2026 16:10 UTC